StonvexLoading…
StonvexCore line items from VST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.59B | $14.76B | $13.80B | $15.63B |
Operating Income | $1.91B | $4.08B | $2.66B | $-1.18B |
Net Income | $944.00M | $2.66B | $1.49B | $-1.23B |
EPS (Diluted) | $2.18 | $7.00 | $3.58 | $-3.26 |
Total Assets | $41.55B | $37.77B | $32.97B | $32.79B |
Total Liabilities | $36.44B | $32.19B | $27.64B | $27.87B |
Cash & Equivalents | $785.00M | $1.19B | $3.48B | $455.00M |
Free Cash Flow OCF − CapEx | $1.32B | $2.48B | $3.78B | $-816.00M |
Shares Outstanding | 338.06M | 339.75M | 351.46M | 389.75M |